UPDATED Jun 25, 2024
Explore the U.S. (NYSE and NASDAQ) Biggest Losers Today. These stocks have seen the largest drop in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
PRCH | US$1.39 | -8.6% | 13.9% | US$150.8m | US$5.41 | PE-1.3x | E36.2% | n/a | Software | ||
ARCB | US$107.03 | -0.5% | 13.8% | US$2.5b | US$143.08 | PE20.8x | E34.6% | 0.4% | Transportation | ||
EVTC | US$33.70 | -0.6% | -6.2% | US$2.2b | US$41.40 | PE33.1x | E22.3% | 0.6% | Diversified Financials | ||
SLRN | US$3.90 | -3.2% | -82.7% | US$399.1m | US$22.50 | PB0.6x | E-0.4% | n/a | Pharmaceuticals & Biotech | ||
AUPH | US$5.57 | -1.6% | -39.0% | US$807.5m | US$10.14 | PS4.2x | E52.0% | n/a | Pharmaceuticals & Biotech | ||
ACCD | US$5.97 | -2.6% | -50.8% | US$490.5m | US$13.07 | PS1.2x | E26.7% | n/a | Healthcare | ||
VYGR | US$7.82 | -2.9% | -32.5% | US$438.1m | US$17.56 | PS3.6x | E-21.8% | n/a | Pharmaceuticals & Biotech | ||
DOX | US$78.29 | -0.1% | -19.0% | US$9.1b | US$100.68 | PE17.2x | E20.5% | 2.4% | Software | ||
AVBP | US$17.48 | -2.1% | n/a | US$598.2m | US$30.20 | PB1.8x | E19.5% | n/a | Pharmaceuticals & Biotech | ||
AMPH | US$40.58 | -0.6% | -27.7% | US$2.0b | US$62.60 | PE12.8x | E16.8% | n/a | Pharmaceuticals & Biotech | ||
RPAY | US$10.45 | -1.2% | 39.0% | US$1.0b | US$12.05 | PS3.2x | E149.9% | n/a | Diversified Financials | ||
RBCA.A | US$49.03 | -1.3% | 15.4% | US$964.4m | US$56.00 | PB1x | E0.6% | 3.3% | Banks | ||
PINC | US$18.47 | -0.6% | -32.3% | US$1.9b | US$21.13 | PE24.1x | E20.8% | 4.5% | Healthcare | ||
TRML | US$14.21 | -3.3% | n/a | US$377.0m | US$58.33 | PB1x | E-15.4% | n/a | Pharmaceuticals & Biotech | ||
RDWR | US$17.34 | -1.7% | -9.1% | US$737.1m | US$19.89 | PS2.8x | E106.2% | n/a | Software | ||
DUOL | US$205.00 | -0.1% | 45.9% | US$8.9b | US$252.23 | PE193.8x | E48.0% | n/a | Consumer Services | ||
ASTL | US$6.99 | -1.7% | -1.4% | US$740.3m | n/a | PE9.4x | S3.1% | 2.9% | Materials | ||
INBX | US$34.11 | -0.7% | 38.7% | US$1.8b | US$35.50 | PS1002.5x | E9.1% | n/a | Pharmaceuticals & Biotech | ||
UFPT | US$259.00 | -0.6% | 35.2% | US$2.0b | US$262.50 | PE41.5x | E10.9% | n/a | Healthcare | ||
EFSC | US$38.40 | -0.9% | -2.0% | US$1.5b | US$46.50 | PB0.9x | E-3.5% | 2.7% | Banks | ||
GRC | US$36.39 | -1.3% | 32.6% | US$966.1m | US$45.00 | PE26.3x | E20.2% | 2.0% | Capital Goods | ||
ABR | US$14.14 | -0.4% | -1.1% | US$2.9b | US$13.54 | PE8.8x | E0.2% | 12.2% | Diversified Financials | ||
BV | US$13.69 | -0.9% | 91.5% | US$1.3b | US$13.67 | PE43.9x | E50.4% | n/a | Commercial Services | ||
LAMR | US$117.78 | -0.1% | 21.5% | US$12.1b | US$121.33 | PB10.2x | E10.2% | 4.4% | Real Estate |